LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.056667
 46.95 84.90 3229 4952 0.6520 0.8594
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 46.95 84.90 277 4952 0.0559 0.2233
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 46.95 84.90 3848 4952 0.7770 0.9158
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 48.65 84.90 114 5328 0.0214 0.0506
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 48.65 84.90 3460 5328 0.6493 0.8605
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 48.65 84.90 318 5328 0.0597 0.2475
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 48.65 84.90 4119 5328 0.7730 0.9156
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 50.36 84.90 163 5651 0.0288 0.1137
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 50.36 84.90 3665 5651 0.6486 0.8620
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 50.36 84.90 347 5651 0.0614 0.2617
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 50.36 84.90 4329 5651 0.7661 0.9139
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 52.06 84.90 171 5990 0.0285 0.1208
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 52.06 84.90 3882 5990 0.6480 0.8636
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 52.06 84.90 355 5990 0.0593 0.2624
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 52.06 84.90 4609 5990 0.7694 0.9164
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 53.77 84.90 191 6252 0.0305 0.1397
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 53.77 84.90 4061 6252 0.6495 0.8656
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 53.77 84.90 418 6252 0.0669 0.2930
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 53.77 84.90 4870 6252 0.7789 0.9210
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 55.48 84.90 189 6567 0.0288 0.1361
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 55.48 84.90 4270 6567 0.6501 0.8673
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 55.48 84.90 423 6567 0.0644 0.2917
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 55.48 84.90 5099 6567 0.7764 0.9209
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 57.18 84.90 206 6963 0.0296 0.1496
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 57.18 84.90 4513 6963 0.6481 0.8681
MN20160318_Q02
E17